Recent Updates
Recently added Catalysts
ALNY Neutral Sentiment Score: 50/100

Alnylam to Host Tenth “RNAi Roundtable” Webcast Series

Key Takeaway: Alnylam Pharmaceuticals is set to host the tenth installment of its 'RNAi Roundtable' webcast series. This event aims to engage stakeholders in discussions about RNA interference technology and its applications. Further details about the webcast, including speakers and topics, have not been provided in the article.

Market Sentiment Analysis

Full Press Release Details

Powered and protected by Privacy
Last updated: Jun 12, 2026